The prognostic implications of these hypoxia-induced changes, particularly HIF-1α activity, were demonstrated in a randomized trial involving over 1100 female patients with 15 years of follow-up, revealing that HIF-1α in hypoxic primary breast tumors is strongly correlated with a greater risk of cancer recurrence and death [55]. The gene discussed is HIF1A; the disease is breast neoplasm.